Located in South San Francisco, California, Tularik Inc. is engaged in the discovery and development of a broad range of novel drugs that act through the regulation of gene expression. Tularik was founded based upon the recognition that inappropriate gene expression lies at the heart of most human diseases. There can be no assurance that Tularik will obtain necessary regulatory approvals for its drug candidates or be able to develop a commercially viable pharmaceutical product. These and other risks are more fully discussed in Tularik's S-1 Registration Statement. Derived from audited consolidated financial statements at that date.
Press releases are only accurate as of their respective dates.
Tularik does not undertake to update this information included in any press release.